We have reported that genetic silencing and pharmacological blockade of mGluR5 reduced the number of mHtt aggregates in male Q111 and zQ175 HD mice, respectively (Ribeiro et al., 2014; Abd-Elrahman et al., 2017). The gene discussed is GRM5; the disease is Huntington disease.